Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+9.86%
-6.83%
+1.36%
-1.12%
-1.93%
SLP
Simulations Plus Inc
$17.33
Chart
$30.25 (-42.71%)
$24 (-27.79%)
$24 (-27.79%)
$38.89 (-55.44%)
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+9.86%
-6.83%
+1.36%
-1.12%
-1.93%
SLP
Simulations Plus Inc
Current Price
$17.33
Login to view Simulations Plus Inc (SLP) recommendation from the last 90 days from financial news and social media.
Chart
$30.25 (-42.71%)
$24 (-27.79%)
$24 (-27.79%)
$38.89 (-55.44%)
SLP Latest Analysis
Drug Development Testing Services Market is expected to reach USD 15 billion by 2034 | Exactitude Consultancy. Luton Bedfordshire United Kingdom June 20 2025 (GLOBE NEWSWIRE) -- The global drug development testing services market is entering a phase of robust expansion driven by a surge in clinical trial activity and innovations in pharmaceutical research. In 2024 the market is valued at an estimated $8.5 billion with projections suggesting a significant increase to nearly $15 billion by 2034. T
Today
Heres Why Hold Strategy is Apt for Illinois Tool Works Stock Now. ITW sees steady growth in key segments and margins but debt concerns and weakness in the MTS Test & Simulation unit cloud the outlook.
Wed Jun 18, 2025
Simulations Pluss SWOT analysis: software strength faces service segment headwinds.
Wed Jun 18, 2025
Pre-Takeoff Safety Checks Market is expected to reach USD 650 billion by 2034 | Exactitude Consultancy. Luton Bedfordshire United Kingdom June 17 2025 (GLOBE NEWSWIRE) -- As of 2024 the global Pre-takeoff Safety Checks Market is valued at approximately $450 billion and is expected to reach around $650 billion by 2034 growing at a Compound Annual Growth Rate (CAGR) of 5.8%. This market encompasses a wide range of products technologies and applications that ensure aviation safety protocols are rig
Tue Jun 17, 2025
InContext Solutions and r4 Technologies Partner to Deliver Groundbreaking Hyperlocal Offering. Joint AI technology provides assortment and arrangement as an AI-powered Service CHICAGO June 16 2025 /PRNewswire/ -- InContext Solutions the global leader in 3D simulation software for retail and r4 Technologies the pioneer of cross-enterprise AI today announce their partnership to...
Mon Jun 16, 2025
Rescale to Provide CAE Hub on NVIDIAs European Industrial AI Cloud to Expand Access to GPU-Accelerated Digital Engineering Simulation. Rescales CAE Hub Will Provide European Engineers and Scientists with Leading-Edge Computing Resources for Digital Simulation and Industrial AI SAN FRANCISCO June 16 2025 /PRNewswire/ -- Rescale a digital engineering platform built for industrial AI accelerated product development...
Mon Jun 16, 2025
HII Selected for United States Armys Live Training Contract. MCLEAN Va. June 16 2025 (GLOBE NEWSWIRE) -- HII'.s (NYSE:) Mission Technologies division is among the companies included on a multiple award contract to provide live training solutions to the United States Army'.s Program Executive Office for Simulation Training and Instrumentation (PEO STRI).The indefinite-delivery indefinite-quantity (IDIQ) contract has a ceiling of $379 million and will enable HII to compete for delivery ord
Mon Jun 16, 2025
Simulations Plus: Further Downside Is Likely (Rating Downgrade).
Fri Jun 13, 2025
Simulations Plus Slashes Guidance Amid Biotech Spending Cuts Analyst Expresses Doubt. ) stock tanked after the company lowered its .The company expects third-quarter sales of $19 million-$20 million much below the consensus of $22.78 million.On Wednesday the company cut its 2025 sales forecast to $76 million—$80 million versus a consensus of $90.26 million down from prior guidance .Also Read: Market uncertainties surrounding future funding drug pricing and potential tariffs are creating signific
Thu Jun 12, 2025
Nvidia Just Partnered With A Weight-Loss Giant But Its Not About Pills. Founder and CEO of ) .Thefirstis with European-based weight loss drug maker ) to accelerate drug discovery and development efforts by leveraging an existing partnership with the Danish Centre for AI Innovation'.s (DCAI) Gefion AI supercomputer.The companies to create customized AI models and agents that Novo Nordisk can use for early research and clinical development and to apply advanced simulation and.Novo Nordisk wil
Thu Jun 12, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Hover over the category for more information
